No Benefit Seen With Everolimus in Early Breast Cancer
Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy
Read moreAdding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy
Read moreGroundbreaking research led by a team of scientists including a University of Massachusetts Amherst biostatistician shows that oral hormone therapy
Read moreTransgender youth are less likely to grapple with depression and suicidal thoughts when they receive early gender-affirming care, according to
Read more